Bull case
CGNX would need investors to value it at roughly 165x earnings — about 114x more generous than today's 50x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where CGNX stock could go
CGNX would need investors to value it at roughly 165x earnings — about 114x more generous than today's 50x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 77x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 11x multiple contraction could push CGNX down roughly 23% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Cognex Corporation is a machine vision technology company that provides systems and software to automate manufacturing and distribution processes through visual inspection and analysis. It generates revenue primarily from hardware sales of vision systems and sensors (~70%) and software licensing (~30%), serving industries like consumer electronics, automotive, and pharmaceuticals. The company's competitive advantage lies in its deep technical expertise, extensive patent portfolio, and established relationships with major manufacturers who rely on its reliable, high-precision vision solutions.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q2 2025 | $0.16/$0.13 | +23.1% | $216M/$249M | -13.2% |
| Q3 2025 | $0.25/$0.23 | +8.7% | $249M/$248M | +0.4% |
| Q4 2025 | $0.33/$0.27 | +22.2% | $277M/$239M | +15.9% |
| Q1 2026 | $0.27/$0.22 | +22.7% | $252M/$239M | +5.6% |
CGNX beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $54 — implies -2.6% from today's price.
| Metric | CGNX | S&P 500 | Technology | 5Y Avg CGNX |
|---|---|---|---|---|
| Forward PE | 50.1x | 19.1x+163% | 21.7x+131% | — |
| Trailing PE | 91.6x | 25.2x+263% | 27.5x+233% | 52.6x+74% |
| PEG Ratio | — | 1.75x | 1.47x | — |
| EV/EBITDA | 52.8x | 15.3x+246% | 17.4x+204% | 38.0x+39% |
| Price/FCF | 43.9x | 21.3x+106% | 19.8x+122% | 47.2x |
| Price/Sales | 10.5x | 3.1x+234% | 2.4x+333% | 8.6x+21% |
| Dividend Yield | 0.52% | 1.88% | 1.18% | 0.66% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolCGNX generates $237M in free cash flow at a 23.8% margin — returns 2.0% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 29, 2026
The machine vision market is highly dynamic, characterized by rapid technological changes and increasing competition. Cognex's ability to maintain its market share and profitability hinges on its capacity to consistently introduce new products with enhanced functionality.
Cognex relies significantly on third-party contractors for manufacturing, which exposes it to supply chain vulnerabilities. Past incidents, such as a fire at a primary contract manufacturer's plant, underscore the risks associated with this reliance.
Cognex's operations and supply chain are vulnerable to geopolitical risks and trade uncertainties, which can disrupt business operations and impact financial performance.
The company's financial results are susceptible to seasonal and cyclical variations in customer purchasing patterns, as well as broader economic volatility, including interest rate hikes and inflation.
Cognex has experienced shrinking adjusted operating margins and declining free cash flow margins over the past five years. The decreasing return on invested capital (ROIC) indicates potential challenges in generating profitable growth.
Cognex's short sales cycle limits visibility into future growth, making its growth trajectory vulnerable to market shifts or slowdowns.
The recent sale of its Japan-focused trading business raises concerns about a smaller revenue base and potentially limited future growth opportunities.
Some analysts consider Cognex's stock to be 'Modestly Overvalued' based on current valuation metrics, despite the company's strong financial health.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 29, 2026
Cognex is a leading provider of machine vision systems, software, sensors, and industrial barcode readers used in manufacturing and logistics automation. Their focus on AI is seen as a significant growth driver.
The company's AI-powered vision and broader market mix are expected to support revenue stability and pricing power. Recent Q4 earnings showed robust revenue, surpassing analyst forecasts, and Q1 projections are also higher than consensus estimates.
Efforts in cost control, operating leverage, and share buybacks are aimed at widening profit margins. The company has also demonstrated strong EBITDA growth and free cash flow generation.
Cognex has a consensus rating of 'Moderate Buy' or 'Buy' from analysts, with a significant portion recommending 'Strong Buy.' The average price target suggests potential upside from the current stock price.
Cognex has a healthy and sustainable dividend payout ratio, and has been increasing its dividend for 10 years.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
CGN CGNX Cognex Corporation | $10.4B | 50.1x | +7.0% | 11.5% | Hold | -3.3% |
KEY KEYS Keysight Technologies, Inc. | $62.9B | 41.2x | +7.7% | 16.9% | Buy | -21.1% |
COH COHU Cohu, Inc. | $2.3B | 93.2x | +0.8% | -11.5% | Buy | +0.3% |
VIA VIAV Viavi Solutions Inc. | $12.3B | 57.3x | +3.7% | -4.0% | Buy | -39.2% |
NOV NOVT Novanta Inc. | $5.0B | 39.0x | +5.3% | 5.5% | Buy | +8.0% |
KLI KLIC Kulicke and Soffa Industries, Inc. | $4.9B | 35.7x | -3.9% | 7.2% | Buy | -33.4% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
CGNX returns capital mainly through $151M/year in buybacks (1.5% buyback yield), with a modest 0.52% dividend — combining for 2.0% total shareholder yield.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.09 | — | — | — |
| 2025 | $0.33 | +6.6% | 2.5% | 3.4% |
| 2024 | $0.30 | +7.0% | 1.1% | 1.9% |
| 2023 | $0.29 | +7.5% | 1.1% | 1.8% |
| 2022 | $0.27 | +8.2% | 2.5% | 3.0% |
Common questions answered from live analyst data and company financials.
Cognex Corporation (CGNX) is rated Hold by Wall Street analysts as of 2026. Of 31 analysts covering the stock, 14 rate it Buy or Strong Buy, 15 rate it Hold, and 2 rate it Sell or Strong Sell. The consensus 12-month price target is $60, implying -3.3% from the current price of $62. The bear case scenario is $48 and the bull case is $204.
The Wall Street consensus price target for CGNX is $60 based on 31 analyst estimates. The high-end target is $70 (+12.4% from today), and the low-end target is $50 (-19.7%). The base case model target is $95.
CGNX trades at 50.1x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for CGNX in 2026 are: (1) Competitive Landscape — The machine vision market is highly dynamic, characterized by rapid technological changes and increasing competition. (2) Supply Chain Vulnerabilities — Cognex relies significantly on third-party contractors for manufacturing, which exposes it to supply chain vulnerabilities. (3) Geopolitical Uncertainties — Cognex's operations and supply chain are vulnerable to geopolitical risks and trade uncertainties, which can disrupt business operations and impact financial performance. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates CGNX will report consensus revenue of $1.0B (+7.0% year-over-year) and EPS of $0.94 (+45.0% year-over-year) for the upcoming fiscal year. The following year, analysts project $1.1B in revenue.
Cognex Corporation is expected to report its next earnings on approximately 2026-05-06. Consensus expects EPS of $0.25 and revenue of $245M. Over recent quarters, CGNX has beaten EPS estimates 92% of the time.
Cognex Corporation (CGNX) generated $237M in free cash flow over the trailing twelve months — a free cash flow margin of 23.8%. CGNX returns capital to shareholders through dividends (0.5% yield) and share repurchases ($151M TTM).